SHANNON WOOD: Open Payments
NPI 1912653221 · SHAWNEE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 78 payments from 9 companies in 2025. Trend: 2023 $776 · 2024 $954 · 2025 $1,024
Food & beverage: $1,024
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $261 |
| Novo Nordisk Inc | 11 | $216 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $206 |
| Otsuka America Pharmaceutical, Inc. | 13 | $159 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Amgen Inc. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
Products named: CAPLYTA, REXULTI, VRAYLAR, Ozempic, QULIPTA, Rybelsus, Kerendia, UBRELVY.
Industry payments across OK — which companies pay providers there.
